Related Experiment Video
Updated: Jan 27, 2026

Implantation of Electrospun Vascular Grafts with Optimized Structure in a Rat Model
Published on: June 27, 2018
Sintered electrospun polycaprolactone for controlled model drug delivery.
Francisco J Chaparro1, Kayla F Presley1, Marco A Coutinho da Silva2
1Department of Materials Science and Engineering, The Ohio State University, 2041 College Road, Columbus, OH 43210, USA.
Sintering electrospun polycaprolactone fibers created capsules for long-term drug delivery. Higher sintering temperatures reduced porosity, controlling drug release over extended periods, with some capsules releasing drugs for over 12 days.
Area of Science:
- Biomaterials Science
- Drug Delivery Systems
- Materials Engineering
Background:
- Electrospinning is a versatile technique for creating fibers for drug delivery.
- Drug loading and release are often limited by surface area.
- Sintering electrospun fibers offers a novel approach for sustained drug release.
Purpose of the Study:
- To investigate the potential of sintered electrospun polycaprolactone (PCL) fibers as capsules for long-term drug delivery.
- To evaluate the effect of sintering temperature on PCL fiber morphology, porosity, and drug release kinetics.
- To correlate PCL capsule properties with the release profiles of model compounds with varying molecular weights.
Main Methods:
- Electrospinning of polycaprolactone (PCL) fibers.
- Sintering of PCL fibers at different temperatures (56-59°C).
- In vitro exposure of PCL fibers and capsules for up to 1042 days.
- Characterization of fiber morphology and pore size.
- Drug release studies using Rhodamine B, Rose Bengal, and BSA-FITC as model compounds.
- COMSOL simulations to model release rates based on capsule properties.
Main Results:
- Electrospun PCL fibers maintained morphology for over 1000 days.
- Sintering significantly decreased pore size, with higher temperatures leading to greater reduction.
- PCL capsules sintered at 58-59°C showed reduced surface porosity but retained entrapped pores.
- Drug release rates were dependent on molecular weight and available porosity (RhB > RB >> BSA-FITC).
- Sintered capsules at 58-59°C exhibited sustained release profiles, continuing after 12 days, unlike those sintered at lower temperatures.
Conclusions:
- Sintering electrospun PCL fibers is a viable method for creating drug-eluting capsules with tunable, long-term release characteristics.
- Controlled reduction of porosity through sintering modulates drug release kinetics, enabling sustained delivery.
- The PCL capsules demonstrate potential for extended performance in drug delivery applications, with release profiles influenced by sintering temperature and molecular properties of the released compound.
More Related Videos
Related Concept Videos
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery: Enteral Route
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Drug Control Governance: Regulatory Bodies and Their Impact
In Vitro Drug Dissolution: Compendial Testing Models I

